Pharma Journalist 8962 posts 0 comments

Abpro and NJCTTQ announced that they have entered into an agreement to develop multiple novel bispecific antibody therapies in immuno-oncology, including best-in-class T-cell engagers.…
Read More...

Sarepta Therapeutics announced that it has exercised its option to acquire Myonexus Therapeutics, a clinical-stage biotechnology company developing transformative gene therapies for…
Read More...

SMi Reports: The countdown begins to the highly anticipated Drug Discovery Chemistry conference in London. The drug discovery field is undergoing dramatic change with a new…
Read More...

PAREXEL International Corporation announced several new appointments that will enhance the company’s oncology expertise as oncology trials grow in number and complexity. First, PAREXEL…
Read More...

PharmOptima, a member of Genesis Drug Discovery & Development (GD3), the contract research organization (CRO) arm of Genesis Biotechnology Group (GBG), and Ophthy-DS, a preclinical…
Read More...

The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG, a biopharmaceutical company pioneering the field of mRNA-based vaccines, have announced a partnership…
Read More...

Amicus Therapeutics announced it is establishing a new Global Research and Gene Therapy Center of Excellence in uCity Square in Philadelphia, PA, to advance its commitment to…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced positive results from the Phase III POLO trial. Results from…
Read More...

Imbrium Therapeutics and TetraGenetics announced a strategic research & development collaboration to utilize TetraGenetics’ antibody discovery technology platform (TetraExpress) in…
Read More...

Selexis SA and Turgut Pharmaceuticals (Turgut Ilaclari A.S.) announced that they have signed two commercial license agreements (CLAs) through which Turgut will leverage Selexis’…
Read More...